Advertisement

November 26, 2012

Big Pharma Buys Influence in Science Journals

Peter Whoriskey, Washington Post


AP Photo

For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup.

The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best.

Read Full Article ››

TAGGED: scientific journals, publication bias, pharmaceutical industry, Big Pharma

RECOMMENDED ARTICLES

November 21, 2012
Science Publication Becoming 50 Shades of Grey
Douglas Fields, HuffPo
Newsweek is dead. But we have Twitter. Harper-Collins just closed its last warehouse of books in the United States. Cambridge University Press, the oldest publisher of scholarly books and journals in the world, printing... more ››
November 19, 2012
Psychology Journal Has a Science Problem
Andrew Wilson, NFTSP
Psychological Science, I think we need to talk. I was reading this farewell from your outgoing editor, and it would all be nice enough if I hadn't also just read your latest offering to the altar of 'embodied' cognition. Frankly,... more ››
|